Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

Chainguard Launches Commercial Builds with Industry Leaders, Setting a New Standard for Verifiable, Zero-Vulnerability Software

prnewswire.com
ESTC GLBZ GRAF TIGR SNOW FTNT HPE OPEN CHKP CAN PANW CRWD ZS DDOG MDB SMCI AMD NVDA INTC AMZN GOOG MSFT IBM ORCL CRM ADBE PYPL NFLX CMCSA DIS VZ T KO PEP JNJ PG XOM CVX UNH JPM BAC WFC C GS MS AMGN GILD BMY PFE MRK ABBV LLY MDT ISRG COST WMT HD MCD SBUX NKE BA CAT GE HON RTX LMT GD MMC AXP V MA MSCI ADP AMAT ASML QCOM AVGO TXN ADSK CDNS SNPS MRVL GOOGL

Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index

prnewswire.com
ABBV

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

globenewswire.com
GMAB ABBV

New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row

globenewswire.com
ABBV

Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
ABBV

Survanta (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
ABBV

Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight

prnewswire.com
ABBV PFE

Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy

prnewswire.com
GILD ASND ABBV

Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight

prnewswire.com
ABBV ALTO NRXP VNDA

CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

prnewswire.com
GILD INCY BIIB NVS AMGN JNJ ABBV BMY AZN MRK PFE TGTX XNCR CABA IMUX ZNTL GLPG CLNN AUTL